OSCR is trading at $29.89 (up 4.3%), extending a strong recent run following upbeat commentary at the Goldman Sachs Healthcare Conference.
- Management recently reaffirmed full-year 2026 guidance, highlighting healthier-than-expected morbidity and supportive membership trends.
- Shares have shown powerful momentum over the past week and year-to-date, with today's move appearing to be a continuation of the existing bullish trend.